Label: LEVOCETIRIZINE DIHYDROCHLORIDE tablet, film coated

  • NDC Code(s): 69230-321-01, 69230-321-10, 69230-321-31, 69230-321-32, view more
    69230-321-33, 69230-321-34
  • Packager: Camber Consumer Care Inc
  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated November 30, 2020

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT(S)

    Levocetirizine dihydrochloride USP 5 mg


  • PURPOSE

    Antihistamine

  • USE(S)

    temporarily relieves these symptoms due to hay fever or other respiratory allergies:
    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat


  • WARNINGS

  • DO NOT USE

    • if you have kidney disease
    • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine



  • ASK A DOCTOR BEFORE USE IF YOU HAVE

    • ever had trouble urinating or emptying your bladder
  • WHEN USING THIS PRODUCT

    •  drowsiness may occur
    •  avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery
  • STOP USE AND ASK A DOCTOR IF

    • you have trouble urinating or emptying your bladder
    • an allergic reaction to this product occurs. Seek medical help right away.


  • IF PREGNANT OR BREAST-FEEDING

    • if breast-feeding: not recommended 
    •  if pregnant: ask a health professional before use
  • KEEP OUT OF REACH OF CHILDREN


    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • DIRECTIONS

                   

     adults 65 years of age and older
         		 
    • ask a doctor
     
     adults and children 12 to 64 years of age
         		 
    • take 1 tablet (5 mg) once daily in the evening  
    • do not take more than 1 tablet (5 mg) in 24 hours 
    • ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
     
     children 6 to 11 years of age
         		 
    • take ½ tablet (2.5 mg) once daily in the evening 
    • do not take more than ½ tablet (2.5 mg) in 24 hours
     
     children under 6 years of age
         		 
    • do not use
     
     consumers with kidney disease
         		 
    • do not use
     

      


  • OTHER INFORMATION

    • store between 20° and 25°C (68° and 77°F)
    • safety sealed: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
    • safety sealed: do not use if carton was opened or if individual blister unit is open or torn



  • INACTIVE INGREDIENTS


    colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, titanium dioxide.

  • QUESTIONS or COMMENTS?

    call 1-888-588-1418.

     


    Distributed by:
    Camber Consumer Care, Inc.

    Piscataway, NJ 08854, USA.


  • PRINCIPAL DISPLAY PANEL


    Levocetirizine Dihydrochloride Tablets USP 5 mg-35's Container carton
     
    Compare to XYZAL® Allergy 24HR Active Ingredient*

    Allergy Relief

    Levocetirizine Dihydrochloride
    Tablets, USP

    5 mg

    Antihistamine

    24 HOUR Relief of

    • Sneezing
    • Runny Nose
    • Itchy Nose or Throat
    • Itchy, Watery Eyes

    Original Prescription Strength

    35 TABLETS
    carton



    Levocetirizine Dihydrochloride Tablets USP 5 mg - 35's Container label

     

    Compare to XYZAL® Allergy 24HR Active Ingredient*

    Allergy Relief

    Levocetirizine Dihydrochloride
    Tablets, USP

    5 mg

    Antihistamine

    24 HOUR Relief of
    •Sneezing
    •Runny Nose
    •Itchy Nose or Throat
    •Itchy, Watery Eyes

    Original Prescription Strength

    35 TABLETS


    bottle label

  • INGREDIENTS AND APPEARANCE
    LEVOCETIRIZINE DIHYDROCHLORIDE 
    levocetirizine dihydrochloride tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69230-321
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEVOCETIRIZINE DIHYDROCHLORIDE (UNII: SOD6A38AGA) (LEVOCETIRIZINE - UNII:6U5EA9RT2O) LEVOCETIRIZINE DIHYDROCHLORIDE5 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    Product Characteristics
    ColorWHITE (White to off white) Score2 pieces
    ShapeOVALSize8mm
    FlavorImprint Code H;LL
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69230-321-311 in 1 CARTON10/28/2020
    135 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:69230-321-321 in 1 CARTON10/28/2020
    255 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:69230-321-331 in 1 CARTON10/28/2020
    380 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:69230-321-101000 in 1 BOTTLE; Type 0: Not a Combination Product10/28/2020
    5NDC:69230-321-0110 in 1 CARTON10/28/2020
    510 in 1 BLISTER PACK; Type 0: Not a Combination Product
    6NDC:69230-321-341 in 1 CARTON10/28/2020
    6180 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21351310/28/2020
    Labeler - Camber Consumer Care Inc (079539968)
    Establishment
    NameAddressID/FEIBusiness Operations
    Hetero Labs Limited Unit III676162024ANALYSIS(69230-321) , MANUFACTURE(69230-321)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!